SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-020845
Filing Date
2022-11-01
Accepted
2022-11-01 16:12:27
Documents
61
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q crsp-20220930.htm   iXBRL 10-Q 2898881
2 EX-31.1 crsp-ex31_1.htm EX-31.1 14924
3 EX-31.2 crsp-ex31_2.htm EX-31.2 14930
4 EX-32.1 crsp-ex32_1.htm EX-32.1 14264
  Complete submission text file 0000950170-22-020845.txt   9646082

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crsp-20220930_lab.xml EX-101.LAB 384168
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crsp-20220930_def.xml EX-101.DEF 168150
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crsp-20220930.xsd EX-101.SCH 42743
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crsp-20220930_cal.xml EX-101.CAL 48079
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crsp-20220930_pre.xml EX-101.PRE 279453
55 EXTRACTED XBRL INSTANCE DOCUMENT crsp-20220930_htm.xml XML 2137570
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37923 | Film No.: 221350359
SIC: 2836 Biological Products, (No Diagnostic Substances)